David Haynes

David Haynes


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2003 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
TCTania Crotti
Tania Crotti
MSMalcolm D. Smith
Malcolm D. Smith
RHRobert Hirsch
Robert Hirsch
SSSteven Soukoulis
Steven Soukoulis
HWHelen Weedon
Helen Weedon
DHDavid Haynes
David Haynes


1 September 2004 in Biomaterials
Verified
Journal Article
Closed access
DHDavid Haynes
David Haynes
TCT.N. Crotti
T.N. Crotti
HZH. Zreiqat
H. Zreiqat

22 February 2011 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MCMelissa D. Cantley
Melissa D. Cantley
DFD.P. Fairlie
D.P. Fairlie
Mark BartoldMark Bartold
Mark Bartold
KRK.D. Rainsford
K.D. Rainsford
GLG.T. Le
G.T. Le
DHDavid Haynes
David Haynes

1 November 2004 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
DHDavid Haynes
David Haynes

27 January 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ADAnak Assk Dharmapatni
Anak Assk Dharmapatni
MSMalcolm D Smith
Malcolm D Smith
DFDavid Findlay
David Findlay
CHChristopher A Holding
Christopher A Holding
AEAndreas Evdokiou
Andreas Evdokiou
DHDavid Haynes
David Haynes
Introduction: Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a tumour necrosis factor (TNF) family member capable of inducing apoptosis in many cell types. Methods: Using immunohistochemistry, terminal deoxynucleotidyl transferase biotin-dUTP nick end labelling (TUNEL) and real-time PCR we investigated the expression of TRAIL, TRAIL receptors and several key molecules of the intracellular apoptotic pathway in human synovial tissues from various types of arthritis and normal controls. Synovial tissues from patients with active rheumatoid arthritis (RA), inactive RA, osteoarthritis (OA) or spondyloarthritis (SpA) and normal individuals were studied. Results: Significantly higher levels of TRAIL, TRAIL R1, TRAIL R2 and TRAIL R4 were observed in synovial tissues from patients with active RA compared with normal controls (p < 0.05). TRAIL, TRAIL R1 and TRAIL R4 were expressed by many of the cells expressing CD68 (macrophages). Lower levels of TUNEL but higher levels of cleaved caspase-3 staining were detected in tissue from active RA compared with inactive RA patients (p < 0.05). Higher levels of survivin and x-linked inhibitor of apoptosis protein (xIAP) were expressed in active RA synovial tissues compared with inactive RA observed at both the protein and mRNA levels. Conclusions: This study indicates that the induction of apoptosis in active RA synovial tissues is inhibited despite stimulation of the intracellular pathway(s) that lead to apoptosis. This inhibition of apoptosis was observed downstream of caspase-3 and may involve the caspase-3 inhibitors, survivin and xIAP.